Discovery and Research

Using QIAGEN Digital Insights to determine how LY6E impairs coronavirus fusion and confers immune control

May 06, 2020
Zoonotic coronaviruses (CoVs) are significant threats to global health, as exemplified by the recent emergence of SARS-CoV-2. Host immune responses to CoV are complex and regulated in part through antiviral interferons. However, the interferon-stimulated gene products that inhibit CoV are not well characterized. In this webinar, we explain the findings of our recent study in which we identified LY6E as a broad coronavirus restriction factor. Our findings advance our understanding of immune-mediated control of CoV in vitro and in vivo and could help in the development of new strategies to combat infection by emerging CoV.

In this webinar, we will discuss:
  • How interferon-inducible lymphocyte antigen 6 complex, locus E (LY6E) restricts cellular infection by multiple CoVs, including SARS-CoV, SARS-CoV-2 and Middle East respiratory syndrome coronavirus (MERS-CoV)
  • Mechanistic studies which reveal that LY6E inhibits CoV entry into cells by interfering with spike protein-mediated membrane fusion
  • How mice lacking Ly6e in hematopoietic cells were highly susceptible to murine CoV infection
  • LY6E as a critical antiviral immune effector that controls CoV infection and pathogenesis
  • The results of our transcriptomic analysis of coronavirus infected mice
  • How QIAGEN Digital Insights supported our transcriptomic analyses and enabled us to gain deeper insights into gene expression during CoV infection

Interested in learning more?




Dr. Stephanie Pfaender, Ph.D., Ruhr University Bochum, Germany, Department for Molecular and Medical Virology

Dr. Daniel Todt, Ph.D., Ruhr University Bochum, Germany, Department for Molecular and Medical Virology

Dr. Jean-Noel Billaud, Ph.D., Senior Principal Scientist, QIAGEN IPA

Related videos


Exploring COVID-19 implicated genes in QIAGEN IPA and OmicSoft Land Explorer

266,834 views April 01, 2020

Interested in learning more? Click here


Analyze, compare and contextualize your biological data with QIAGEN IPA

69,052 views June 07, 2023

Discover why QIAGEN Ingenuity Pathway Analysis (IPA) is more than just...


IPA Webinar: Part 1: Introduction to Ingenuity Pathway Analysis

38,865 views November 12, 2019

Learn how to quickly and easily identify significant pathways, discover...


IPA Webinar: Part 2: Formatting and Uploading Your Dataset into IPA

19,912 views November 12, 2019

IPA has broadly been adopted by the life science research community and is...